Literature DB >> 7602222

Prevalence of maxillary sinusitis in leprous individuals from a medieval leprosy hospital.

P A Boocock1, C A Roberts, K Manchester.   

Abstract

The maxillary sinuses of 133 skeletons from the medieval hospital of St. James and St. Mary Magdalene, Chichester, England, were analyzed for evidence of sinusitis. Of the sample, 16 individuals were considered to have suffered from lepromatous leprosy and 13 from tuberculoid leprosy. The most common bone change seen within the sinuses was the presence of new bone formation followed by pitting. Bone change was seen in 56.3% (9 of 16) of the individuals with lepromatous leprosy and 54.8% (57 of 104) of nonleprous individuals. These results are not statistically significant. Clinical evidence suggests that one should see a higher frequency in the lepromatous group. Possible explanations of this include environmental factors promoting the spread of droplet infection in an immunosuppressed community, in addition to which the small sample of leprous skeletons may bias the result.

Entities:  

Mesh:

Year:  1995        PMID: 7602222

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  2 in total

1.  The two extremes of Hansen's disease-Different manifestations of leprosy and their biological consequences in an Avar Age (late 7th century CE) osteoarchaeological series of the Duna-Tisza Interfluve (Kiskundorozsma-Daruhalom-dűlő II, Hungary).

Authors:  Olga Spekker; Balázs Tihanyi; Luca Kis; Orsolya Anna Váradi; Helen D Donoghue; David E Minnikin; Csaba Szalontai; Tivadar Vida; György Pálfi; Antónia Marcsik; Erika Molnár
Journal:  PLoS One       Date:  2022-06-23       Impact factor: 3.752

2.  Life and death of a leprosy sufferer from the 8th-century-CE cemetery of Kiskundorozsma-Kettőshatár I (Duna-Tisza Interfluve, Hungary)-Biological and social consequences of having Hansen's disease in a late Avar Age population from Hungary.

Authors:  Olga Spekker; Balázs Tihanyi; Luca Kis; Csaba Szalontai; Tivadar Vida; György Pálfi; Antónia Marcsik; Erika Molnár
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.